PEN Q1 2019 Earnings — Penumbra, Inc. Revenue & Financial Results | Market Cap Arena

PENPenumbra, Inc.

$13B

Q1 2019 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$128M+25.1% YoY

Gross Profit

$84M65.3% margin

Operating Income

$11M8.7% margin

Net Income

$11M8.3% margin

EPS (Diluted)

$0.30

QoQ Revenue Growth

+6.3%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$5M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$569M

Total Liabilities

$132M

Stockholders' Equity

$437M

Cash & Equivalents

$96M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$128M	$103M	+25.1%
Gross Profit	$84M	$67M	+26.1%
Operating Income	$11M	$4M	+175.7%
Net Income	$11M	$5M	+94.8%

Revenue Segments

Neuro

$81M63%

Peripheral Vascular

$47M37%

Geographic Segments

UNITED STATES

$83M64%

Other Non-US

$36M28%

JAPAN

$10M7%